Literature DB >> 31612242

Aflatoxin B1 enhances pyroptosis of hepatocytes and activation of Kupffer cells to promote liver inflammatory injury via dephosphorylation of cyclooxygenase-2: an in vitro, ex vivo and in vivo study.

Li-Yin Zhang1, Deng-Lin Zhan1, Yuan-Yuan Chen1, Wei-Hua Wang1, Cheng-Yong He1, Yi Lin1, Yu-Chun Lin2, Zhong-Ning Lin3.   

Abstract

Aflatoxin B1 (AFB1), a food contaminant derived from Aspergillus fungi, has been reported to cause hepatic immunotoxicity via inflammatory infiltration and cytokines release. As a pro-inflammatory factor, cyclooxygenase-2 (COX-2) is widely involved in liver inflammation induced by xenobiotics. However, the mechanism by which AFB1-induced COX-2 regulates liver inflammatory injury via hepatocytes-Kupffer cells (KCs) crosstalk remains unclear and requires further elucidation. Here, we established a COX-2 upregulated model with AFB1 treatment in vivo (C57BL/6 mice, 1 mg/kg body weight, i.g, 4 weeks) and in vitro (human liver HepaRG cells, 1 μM for 24 h). In vivo, AFB1-treated mice exhibited NLRP3 inflammasome activation, inflammatory infiltration, and increased recruitment of KCs. In vitro, dephosphorylated COX-2 by protein phosphatase 2A (PP2A)-B55δ promoted NLRP3 inflammasome activation, including mitochondrial translocation of NLRP3, caspase 1 cleavage, and IL-1β release. Moreover, phosphorylated COX-2 at serine 601 (p-COX-2Ser601) underwent endoplasmic reticulum (ER) retention for proteasome degradation. Furthermore, pyroptosis and inflammatory response induced by AFB1 were relieved with COX-2 genetic (siPTGS2) intervention or pharmaceutic (celecoxib, 30 mg/kg body weight, i.g, 4 weeks) inhibition of COX-2 via NLRP3 inflammasome suppression in vivo and in vitro. Ex vivo, in a co-culture system with murine primary hepatocytes and KCs, activated KCs induced by damaged signals from pyroptotic hepatocytes, formed a feedback loop to amplify NLRP3-dependent pyroptosis of hepatocytes via pro-inflammatory signaling, leading to liver inflammatory injury. Taken together, our data suggest a novel mechanism that protein quality control of COX-2 determines the intracellular distribution and activation of NLRP3 inflammasome, which promotes liver inflammatory injury via hepatocytes-KCs crosstalk.

Entities:  

Keywords:  Aflatoxin B1; Cyclooxygenase-2; Kupffer cells; Liver inflammatory injury; NLRP3 inflammasome; Protein phosphatase 2A

Year:  2019        PMID: 31612242     DOI: 10.1007/s00204-019-02572-w

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  18 in total

1.  Deoxynivalenol induces caspase-3/GSDME-dependent pyroptosis and inflammation in mouse liver and HepaRG cells.

Authors:  Xiaoxiao Mao; Jie Li; Xin Xie; Shuang Chen; Qiang Huang; Peiqiang Mu; Jun Jiang; Yiqun Deng
Journal:  Arch Toxicol       Date:  2022-08-04       Impact factor: 6.168

2.  Apigeninidin-enriched Sorghum bicolor (L. Moench) extracts alleviate Aflatoxin B1-induced dysregulation of male rat hypothalamic-reproductive axis.

Authors:  Solomon E Owumi; Moses T Otunla; Uche O Arunsi; Adegboyega K Oyelere
Journal:  Exp Biol Med (Maywood)       Date:  2022-06-06

3.  Pretreatment of Indobufen and Aspirin and their Combinations with Clopidogrel or Ticagrelor Alleviates Inflammasome Mediated Pyroptosis Via Inhibiting NF-κB/NLRP3 Pathway in Ischemic Stroke.

Authors:  Fengyang Li; Dan Xu; Kai Hou; Xue Gou; Ning Lv; Weirong Fang; Yunman Li
Journal:  J Neuroimmune Pharmacol       Date:  2021-01-29       Impact factor: 4.147

4.  NLRP3 inflammasome inhibitor MCC950 attenuates primary dysmenorrhea in mice via the NF-κB/COX-2/PG pathway.

Authors:  Biao Tang; Dan Liu; Lingyu Chen; Yu Liu
Journal:  J Inflamm (Lond)       Date:  2020-06-24       Impact factor: 4.981

Review 5.  Aflatoxin Detoxification Using Microorganisms and Enzymes.

Authors:  Yun Guan; Jia Chen; Eugenie Nepovimova; Miao Long; Wenda Wu; Kamil Kuca
Journal:  Toxins (Basel)       Date:  2021-01-09       Impact factor: 4.546

Review 6.  Emerging recognition of the complement system in hepatic ischemia/reperfusion injury, liver regeneration and recovery (Review).

Authors:  Zhi-Gao Hu; Yi Zhou; Cheng-Jie Lin; Guan-Dou Yuan; Song-Qing He
Journal:  Exp Ther Med       Date:  2021-01-18       Impact factor: 2.447

7.  Systems Pharmacology Study of the Anti-Liver Injury Mechanism of Citri Reticulatae Pericarpium.

Authors:  Jianxiong Wu; Xietao Ye; Songhong Yang; Huan Yu; Lingyun Zhong; Qianfeng Gong
Journal:  Front Pharmacol       Date:  2021-04-12       Impact factor: 5.810

8.  Effects of compound probiotics and aflatoxin-degradation enzyme on alleviating aflatoxin-induced cytotoxicity in chicken embryo primary intestinal epithelium, liver and kidney cells.

Authors:  Hong-Wei Guo; Juan Chang; Ping Wang; Qing-Qiang Yin; Chao-Qi Liu; Xiao-Xiang Xu; Xiao-Wei Dang; Xiao-Fei Hu; Quan-Liang Wang
Journal:  AMB Express       Date:  2021-03-01       Impact factor: 3.298

Review 9.  Contamination of Aflatoxins Induces Severe Hepatotoxicity Through Multiple Mechanisms.

Authors:  Zhenglai Hua; Rui Liu; Youwen Chen; Guangzhi Liu; Chenxi Li; Yurong Song; Zhiwen Cao; Wen Li; Weifeng Li; Cheng Lu; Yuanyan Liu
Journal:  Front Pharmacol       Date:  2021-01-11       Impact factor: 5.810

10.  Melatonin attenuates AFB1-induced cardiotoxicity via the NLRP3 signalling pathway.

Authors:  Hui Yan; Junhua Ge; Hongrui Gao; Yang Pan; Yan Hao; Jian Li
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.